Pfizer Strengthens Supplement Business

In an effort to strengthen its supplement portfolio, Pfizer Inc., New York, NY, has entered an agreement to purchase Ferrosan’s consumer healthcare business, based in Copenhagen, Denmark, from Altor 2003 Fund GP Limited. Ferrosan is a consumer healthcare company established in the Nordic region with a portfolio of leading brands. Since 1920, Ferrosan has grown to serve a broader market including Russia, the Ukraine, Poland, Turkey and many countries throughout Central and Eastern Europe. “Ferrosan is an excellent strategic fit that strengthens our presence in dietary supplements with a new set of compelling brands and product pipeline,” said Paul Sturman, president, Pfizer Consumer Healthcare. “The transaction will mark an important step towards expanding Ferrosan’s brands through Pfizer’s global footprint.” Ferrosan’s portfolio includes Multi-tabs, a multivitamin brand, Bifiform, a probiotic, Fri Flyt/Active Omega and IMEDEEN premium oral skincare brands.